Pathways Neuro Pharma, Inc.
Home
Solutions
  • Juvenile Parkinson's
  • Intellectual Property
Science
  • Gene Therapy
  • Pharmaceutical Discovery
About
Contact
NEWS
  • Press Releases & Podcasts
  • Papers & Presentations
Pathways Neuro Pharma, Inc.
Home
Solutions
  • Juvenile Parkinson's
  • Intellectual Property
Science
  • Gene Therapy
  • Pharmaceutical Discovery
About
Contact
NEWS
  • Press Releases & Podcasts
  • Papers & Presentations
More
  • Home
  • Solutions
    • Juvenile Parkinson's
    • Intellectual Property
  • Science
    • Gene Therapy
    • Pharmaceutical Discovery
  • About
  • Contact
  • NEWS
    • Press Releases & Podcasts
    • Papers & Presentations
  • Home
  • Solutions
    • Juvenile Parkinson's
    • Intellectual Property
  • Science
    • Gene Therapy
    • Pharmaceutical Discovery
  • About
  • Contact
  • NEWS
    • Press Releases & Podcasts
    • Papers & Presentations

LIVING YOUR BEST LIFE

LIVING YOUR BEST LIFELIVING YOUR BEST LIFELIVING YOUR BEST LIFE

 

  A new era in gene therapy for treating the intersection of pathways that control disease. 

Learn More

Our Mission

Our Technology

Our Technology

 At Pathways Neuro Pharma, we strive to significantly impact the lives of individuals suffering from Juvenile Parkinson’s and other rare neurological disorders by providing innovative, effective, and safer therapeutic solutions that improve patient outcomes. 

Our Technology

Our Technology

Our Technology

 Utilizing an advanced expression plasmid, our platform offers a safer, more efficient method for delivering therapeutic genes directly to the brain. Our plasmid's ability to sustain gene expression for up to 15 months holds significant promise for improving patient outcomes.  

Our Vision

Our Technology

Our Vision

 Develop a combination therapy approach for (1) gene therapy to restore and enhance levels of  neuro-regulators, and (2) pharmaceutical activators to stimulate regulatory function.

Our purpose is to revolutionize the treatment of Juvenile Parkinson’s and other rare neurological disorders. By focusing on innovative therapies that address neurological mechanisms, we aim to provide effective, safer solutions that offer hope and significantly improve the lives of those affected.”


Anthony Mack, President and CEO

Want to Learn More?

Contact us~

Pathways Announces Strategic Focus on Rare Pediatric Diseases, Led by Juvenile Parkinson’s Disease

Pathways Announces Strategic Focus on Rare Pediatric Diseases, Led by Juvenile Parkinson’s Disease

Pathways Announces Strategic Focus on Rare Pediatric Diseases, Led by Juvenile Parkinson’s Disease

Pathways Announces Strategic Focus on Rare Pediatric Diseases, Led by Juvenile Parkinson’s Disease

Pathways Announces Strategic Focus on Rare Pediatric Diseases, Led by Juvenile Parkinson’s Disease

Pathways Announces Strategic Focus on Rare Pediatric Diseases, Led by Juvenile Parkinson’s Disease

Connect With Us

Copyright © 2024 PathwaysNP,  

18205 Burkhardt Road, Tomball, Texas 77377, United States

  - All Rights Reserved.

  • Home
  • Juvenile Parkinson's
  • Gene Therapy
  • Pharmaceutical Discovery
  • Contact
  • Press Releases & Podcasts
  • Papers & Presentations

Powered by